Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-10-010882
Filing Date
2010-04-09
Accepted
2010-04-09 17:24:48
Documents
2
Period of Report
2010-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 6249
2 POWER OF ATTORNEY doc1.txt EX-24 2847
  Complete submission text file 0001127602-10-010882.txt   10948
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address OSI PHARMACEUTICALS, INC. 41 PINELAWN RD. MELVILLE NY 11747
Business Address
Davies Angela M. (Reporting) CIK: 0001488772 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15190 | Film No.: 10743345